GRISEOFULVIN, ULTRAMICROSIZE (GRISEOFULVIN, ULTRAMICROSIZE) — FDA Approval ANDA202805 (SANDOZ)
GRISEOFULVIN, ULTRAMICROSIZE (GRISEOFULVIN, ULTRAMICROSIZE) — FDA Approval ANDA202805 (SANDOZ) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: GRISEOFULVIN, ULTRAMICROSIZE; Active ingredients: GRISEOFULVIN, ULTRAMICROSIZE; Application number: ANDA202805.
| Brand name | GRISEOFULVIN, ULTRAMICROSIZE |
|---|---|
| Active ingredients | GRISEOFULVIN, ULTRAMICROSIZE |
| Application number | ANDA202805 |
| Sponsor | SANDOZ |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20181226 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →